Timothy Kennedy serves as Executive at BIOCEPT INC, where they oversee executive responsibilities. Since joining the company, Timothy Kennedy has executed 3 insider transactions totaling $40.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 31, 2017 involved receiving (via award) 25,000 shares valued at $0.
Timothy Kennedy currently holds 86,363 shares of BIOCEPT INC (BIOC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Timothy Kennedy has been a net buyer of BIOC stock. They have purchased $40.0K and sold $0 worth of shares.
Timothy Kennedy's most recent insider trade was on May 31, 2017, when they sold 25,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.10 |
| Discretionary |
| Jul 29, 2016 | BIOC | $0 | Award | 75,000 | $N/A | Discretionary |